📰 Institut Pasteur News
Page 9 - Institut Pasteur News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Institut Pasteur. Real-time updates on events, politics, business and more.
February 14, 2024
The study also found that the more someone smoked, the more it changed their immune response.
February 14, 2024
The study also found that the more someone smoked, the more it changed their immune response.
February 14, 2024
The study also found that the more someone smoked, the more it changed their immune response.
February 3, 2024
Five studies, including at least three with ties to Boston, are using rival gene therapies to treat a hearing disorder caused by mutations in a single gene, called otoferlin.
February 2, 2024
The Nobel Prize in Physiology or Medicine 2008 was divided, one half awarded to Harald zur Hausen "for his discovery of human papilloma viruses causing cervical cancer", the other half jointly to Françoise Barré-Sinoussi and Luc Montagnier "for their discovery of human immunodeficiency virus"
February 2, 2024
The Nobel Prize in Physiology or Medicine 2008 was divided, one half awarded to Harald zur Hausen "for his discovery of human papilloma viruses causing cervical cancer", the other half jointly to Françoise Barré-Sinoussi and Luc Montagnier "for their discovery of human immunodeficiency virus"
February 1, 2024
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces the recruitment of the last patien...
January 27, 2024
Many researchers suspect that the disease is triggered by a virus, known as Epstein-Barr, which causes the immune system to attack the nerves and can leave patients struggling to walk or talk. But the virus cant be the whole story, since nearly everyone is infected with it at some point in life.
January 25, 2024
Early treatment correlates with post-treatment infection control, hinting at a potential window for promoting HIV remission.